Kanoria Chemicals FY2026: Revenue up 29%, EBITDA up 52% as efficiency gains show through

Standalone operating revenue was INR 875.34 crore and EBITDA was INR 81.58 crore in FY2026.

Standalone EBITDA margin increased to 9.3% in FY2026 from 7.9% in FY2025.

Formaldehyde (37%) 47%, Pentaerythritol 13%, Methanol trading 12%, Hexamine 11%, Phenol FDH resin 10%, Others 7%.

Consolidated operating revenue was INR 981.43 crore and consolidated net profit was INR 113.19 crore in FY2026.

The presentation states APAG Holding AG, Switzerland ceased to be a subsidiary during the year, so its results are shown as discontinued operations, including a gain on loss of control of INR 97.65 crore.

The presentation mentions Vision 2030, diversification into Triacetin and Penta derivatives expected to be commissioned shortly, capacity additions in Formaldehyde and Resin, and ongoing process and supply chain cost reduction programs.

The presentation notes exposure to currency volatility, inflation and changes in government policy in Ethiopia.